|Bid||0.00 x 900|
|Ask||0.00 x 900|
|Day's Range||127.94 - 132.30|
|52 Week Range||61.96 - 260.98|
|Beta (3Y Monthly)||0.15|
|PE Ratio (TTM)||33.08|
|Earnings Date||Mar 4, 2019 - Mar 8, 2019|
|Forward Dividend & Yield||3.00 (2.24%)|
|1y Target Est||226.67|
If you are interested in cashing in on Medifast, Inc.'s (NYSE:MED) upcoming dividend of US$0.75 per share, you only have 3 days left to buy the shares before its ex-dividend Read More...
The quarterly cash dividend of $0.75 per share is payable on February 7, 2019 to stockholders of record as of the close of business on December 21, 2018. "This increase reflects our confidence in the business as well our commitment to deliver attractive total stockholder returns," said Dan Chard, Chief Executive Officer of Medifast.
Medifast Inc (NYSE:MED) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In the case Read More...
BALTIMORE, Nov. 14, 2018 /PRNewswire/ -- Medifast, Inc. (MED), a leading manufacturer and distributor of clinically proven, healthy living products and programs, today announced it has completed a $10 million stock repurchase. This repurchase was made as part of the Company's existing stock repurchase program that was previously approved by its Board of Directors. "Our stock repurchase demonstrates the confidence our Board of Directors and executive team has in Medifast's long-term growth trajectory and the strength of our balance sheet and cash flow," said Tim Robinson, Chief Financial Officer of Medifast.
The sharp drop comes as Medifast's stock has been one of the biggest movers of the year, rising more than three-fold since January to an all-time high of $248.98 on Sept. 10.
Medifast (MED) delivered earnings and revenue surprises of -0.87% and 11.04%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Baltimore-based company said it had net income of $1.14. The weight-loss company posted revenue of $139.2 million in the period. For the current quarter ending in December, Medifast ...
Third Quarter Revenue Increased 80% and EPS Increased 107% Record Financial Results Exceed Third Quarter Guidance Raises Fiscal Year 2018 Outlook BALTIMORE , Nov. 6, 2018 /PRNewswire/ -- Medifast, Inc. ...
The hires come as fast-growing Medifast readies to begin selling its weight-loss products in Hong Kong and Singapore.
Medifast (MED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BALTIMORE, Oct. 30, 2018 /PRNewswire/ -- Medifast (MED), a leading manufacturer and distributor of clinically proven, healthy living products and programs, today announced the appointment of Tony Tyree as Chief Marketing Officer and Fran Lawler as Chief Human Resources Officer, adding to the company's expert leadership team as it prepares for international expansion with its lifestyle brand and Coach community, OPTAVIA®. Tyree and Lawler, whose appointments follow those of Nicholas Johnson, President of OPTAVIA, USA, and Clovis Lau, Vice President Business Development, Asia-Pacific, will be instrumental in scaling the company's growth in new and existing markets including Hong Kong and Singapore in 2019.
BALTIMORE , Oct. 23, 2018 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven, healthy living products and programs, will announce financial results ...
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return Read More...
Hain Celestial (HAIN) is expected to further gain from its Project Terra program and strategic acquisitions amid high expenses and soft U.S. segment sales.
Given that both the United States and China are imposing tit-for-tat tariffs, the trade war is unlikely to end anytime soon.